Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries PlatformExpected to Be Accretive to Adjusted Earnings Per Share1WALTHAM, Mass. (BUSINESS WIRE) Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has c.
Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries Platform
Expected to Be Accretive to Adjusted Earnings Per Share1
. -Today at 04:12 pm- MarketScreener
Thermo Fisher Scientific Selected as the Transplantation Statistical and Clinical Coordinating Center (T-SCCC) for the U S National Institute of Allergy and Infectious Diseases streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
T-SCCC will support initiatives seeking to ensure success of organ transplants for patientsWILMINGTON, N.C. (BUSINESS WIRE) The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been granted a five-year award to provide a Transplantation Statistical and Clini.
Thermo Fisher Scientific Inc. announced today that it has priced an offering of $2.95 billion aggregate principal amount of the following notes, each issued at par:
$600 million aggregate.